These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Unlocking the mysterious mechanisms of Myc. Nat Med; 2013 Jan; 19(1):26-7. PubMed ID: 23296005 [No Abstract] [Full Text] [Related]
11. Oncogene addiction: sometimes a temporary slavery. Jonkers J; Berns A Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957 [TBL] [Abstract][Full Text] [Related]
12. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382 [TBL] [Abstract][Full Text] [Related]
13. JNK1 and JNK2 play redundant functions in Myc-induced B cell lymphoma formation. Anbalagan M; Sabapathy K Int J Cancer; 2012 Apr; 130(8):1967-9. PubMed ID: 21630260 [No Abstract] [Full Text] [Related]
15. Mouse Models of Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y Front Immunol; 2020; 11():1564. PubMed ID: 32793219 [TBL] [Abstract][Full Text] [Related]
16. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas. Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer. Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793 [TBL] [Abstract][Full Text] [Related]
18. De novo Richter transformation. Chiecchio L; Cullis JO Blood; 2017 Apr; 129(17):2455. PubMed ID: 28450576 [No Abstract] [Full Text] [Related]
19. Transcriptional regulation and transformation by Myc proteins. Adhikary S; Eilers M Nat Rev Mol Cell Biol; 2005 Aug; 6(8):635-45. PubMed ID: 16064138 [TBL] [Abstract][Full Text] [Related]
20. Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. Hoellein A; Fallahi M; Schoeffmann S; Steidle S; Schaub FX; Rudelius M; Laitinen I; Nilsson L; Goga A; Peschel C; Nilsson JA; Cleveland JL; Keller U Blood; 2014 Sep; 124(13):2081-90. PubMed ID: 25143484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]